alexa
Indianmoney.com Missed Call Number
 
Home News Delhi High Court quashes Cipla's appeal, can't market generics of Novartis' Onbrez

Read more interesting news from around the globe with Indianmoney App

Google Play
 
Get the Best Financial Advice on Medical LoanClick Here
 
 
Delhi High Court quashes Cipla's appeal, can't market generics of Novartis' Onbrez

Delhi High Court quashes Cipla's appeal, can't market generics of Novartis' Onbrez

Thursday, March 9, 2017, 5:35 PM

Onbrez, Novartis' brand of the chemical drug indacaterol, is used to treat chronic obstructive pulmonary disease (COPD). Indian drug maker Lupin Ltd imports and markets Onbrez here through a 2012 agreement with Novartis. Justices Badar Durrez Ahmed and Sanjeev Sachdeva on Thursday dismissed Cipla's appeal to an earlier ruling by the Delhi High Court on several grounds.
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

Get It now!